Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer. Chalasani P, Farr K, Wu V, Jenkins I, et al. Breast Cancer Res Treat 2021 Apr 2. pii: 10.1007/s10549-021-06175.

Read + Share

Amedeo Smart

Independent Medical Education

Chalasani P, Farr K, Wu V, Jenkins I, et al. Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer. Breast Cancer Res Treat 2021 Apr 2. pii: 10.1007/s10549-021-06175.
PMID: 33797651